You are currently browsing the archives for 7 August 2016.
Displaying 1 entry.

The scientists showed future.

Kettritz and colleagues tested three of these drugs – epifibatide abciximab and tirofiban – on cell cultures in which neutrophils the GPIIb / IIIa receptors from platelets had received and confirmed the drug effects on inflammation. The scientists showed future, theseee drugs reduced the production of TNF, the inflammation in these cells inhibited. These findings led the researchers speculate that some of the positive effects of the three drugs in patients with acute coronary syndrome the result of their anti-inflammatory properties.

Besides neutrophils, two other types of white blood cells called macrophages and lymphocytes, which intervene in the control of bacteria. These by a chemical by a chemical compound called released tumor necrosis factor by the neutrophils. Although there are several ways by which neutrophils release TNF are, took Kettritz and colleagues, the GPIIb /l membranes. At neutrophils are stimulated to produce TNF in a totally new and different way.